IL6 and COVID-19: McElvaney and co-workers15 found that the interleukin-6 (IL-6):AAT ratio is markedly elevated in critically ill patients with COVID-19 compared with healthy volunteers or stable hospitalized COVID-19 patients; this ratio also directly correlated with prolonged hospital stay and mortality.